GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS AND PROTECTION AGAINST STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Milionis, H. [1 ]
Barkas, F. [1 ]
Elisaf, M. [1 ]
机构：
[1] Univ Ioannina, Dept Internal Med, Ioannina, Greece
来源：
ATHEROSCLEROSIS | 2018年 / 275卷
关键词：
D O I：
10.1016/j.atherosclerosis.2018.06.170
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAG27.1
引用
收藏
页码：E62 / E62
页数：1
相关论文
共 50 条
  • [31] Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta-analysis
    Avgerinos, Ioannis
    Karagiannis, Thomas
    Malandris, Konstantinos
    Liakos, Aris
    Mainou, Maria
    Bekiari, Eleni
    Matthews, David R.
    Tsapas, Apostolos
    DIABETES OBESITY & METABOLISM, 2019, 21 (01): : 188 - 193
  • [32] Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Fragakis, Nikolaos
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2025, 164
  • [33] Glucagon-Like Peptide-1 Receptor Agonists in the Management of Obesity: An Economics Meta-Analysis
    Bloomfield, Grace C.
    Chen, Yuan
    Cunningham, Marcus H.
    Bartoletti, Sebastiano
    Azagury, Dan E.
    Alimi, Yewande R.
    Prindeze, Nicholas
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S25 - S25
  • [34] Glucose Lowering Efficacy of Glucagon-Like Peptide-1 Receptor Agonists: A Meta-Analysis
    Vilsboll, Tina
    Christensen, Mikkel
    Knop, Filip K.
    Gluud, Lise L.
    DIABETES, 2011, 60 : A295 - A295
  • [35] Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis
    Monami, Matteo
    Dicembrini, Ilaria
    Omarchionni, Niccolo
    Rotella, Carlo M.
    Mannucci, Edoardo
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [36] Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis
    Krisanapan, Pajaree
    Suppadungsuk, Supawadee
    Sanpawithayakul, Kanokporn
    Thongprayoon, Charat
    Pattharanitima, Pattharawin
    Tangpanithandee, Supawit
    Mao, Michael A.
    Miao, Jing
    Cheungpasitporn, Wisit
    CLINICAL KIDNEY JOURNAL, 2024, 17 (02)
  • [37] Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis
    Karakasis, Paschalis
    Fragakis, Nikolaos
    Patoulias, Dimitrios
    Theofilis, Panagiotis
    Kassimis, George
    Karamitsos, Theodoros
    El-Tanani, Mohamed
    Rizzo, Manfredi
    ADVANCES IN THERAPY, 2024, 41 (10) : 3749 - 3756
  • [38] Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials
    Figlioli, Gisella
    Piovani, Daniele
    Peppas, Spyros
    Pugliese, Nicola
    Hassan, Cesare
    Repici, Alessandro
    Lleo, Ana
    Aghemo, Alessio
    Bonovas, Stefanos
    PHARMACOLOGICAL RESEARCH, 2024, 208
  • [39] Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials
    Salamah, Hazem Mohamed
    Marey, Ahmed
    Abugdida, Mohamed
    Abualkhair, Khaled Alsayed
    Elshenawy, Salem
    Elhassan, Wael Atif Fadl
    Naguib, Mostafa Mahmoud
    Malnev, Dmitrii
    Durrani, Jamrose
    Bailey, Ronelle
    Tsyunchyk, Anastasiia
    Ibrahim, Lena
    Zavgorodneva, Zhanna
    Sherazi, Andleeb
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [40] Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials
    Silverii, Giovanni Antonio
    Monami, Matteo
    Gallo, Marco
    Ragni, Alberto
    Prattichizzo, Francesco
    Renzelli, Valerio
    Ceriello, Antonio
    Mannucci, Edoardo
    DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 891 - 900
12345